Preferred Label : glucarpidase;

MeSH Related Number : EC 3.4.17.11;

UNII : 2GFP9BJD79;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://ansm.sante.fr/tableau-acces-derogatoire/voraxaze-1000-u-poudre-pour-solution-pour-perfusion
2024
false
false
false
France
French
glucarpidase
drug information

---
https://www.has-sante.fr/jcms/p_3361532/fr/voraxaze-glucarpidase-reduction-de-la-concentration-plasmatique-toxique-de-methotrexate
2022
false
false
false
France
Methotrexate Toxicity
Methotrexate Toxicity
insurance, health, reimbursement
treatment outcome
adult
adolescent
child
methotrexate
methotrexate
glucarpidase
guidelines for drug use
injections, intravenous
evaluation of the transparency committee
glucarpidase
methotrexate
Voraxaze

---
https://www.has-sante.fr/jcms/p_3334621/fr/voraxaze-glucarpidase
https://www.has-sante.fr/jcms/p_3334731/fr/decision-n-2022-0235/dp/sem-du-25-avril-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-voraxaze
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
methotrexate
Methotrexate Toxicity
Methotrexate Toxicity
adult
child
glucarpidase
injections, intravenous
evaluation of the transparency committee
Voraxaze
glucarpidase

---
https://www.ema.europa.eu/en/medicines/human/EPAR/voraxaze-0
2022
false
false
false
Netherlands
French
English
glucarpidase
glucarpidase
glucarpidase
orphan drug production
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
adult
adolescent
infant
aged
Methotrexate toxicity
methotrexate
injections, intravenous
methotrexate
methotrexate
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.